IDXX Q2 2020 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$638M+2.8% YoY

Gross Profit

$379M59.5% margin

Operating Income

$193M30.3% margin

Net Income

$149M23.4% margin

EPS (Diluted)

$1.72

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

$208M

Free Cash Flow

$184M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.7B

Stockholders' Equity

$273M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$638M	$620M	+2.8%
Gross Profit	$379M	$358M	+6.0%
Operating Income	$193M	$164M	+17.6%
Net Income	$149M	$126M	+18.5%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$2.0B97%

Reagent Rental Programs

$27M1%

Extended Warranties And Post Contract Support

$22M1%

Instrument Rebate Programs

$4M0%

Geographic Segments

UNITED STATES

$406M64%

EMEA

$124M19%

Asia Pacific

$72M11%

CANADA

$25M4%

Latin America

$11M2%